Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study— <scp>IL PSO</scp> ( <scp>Italian landscape psoriasis</scp> )-Reference-Cited by-同舟云学术

Real‐life effectiveness of tildrakizumab in chronic plaque psoriasis: A 52‐week multicentre retrospective study— IL PSO ( Italian landscape psoriasis )

Published:2022-10-05 Issue:1 Volume:37 Page:93-103
ISSN:0926-9959
Container-title:Journal of the European Academy of Dermatology and Venereology
language:en
Short-container-title:Acad Dermatol Venereol

Author:

Narcisi Alessandra¹²,Valenti Mario¹²^ORCID,Gargiulo Luigi¹²^ORCID,Ibba Luciano¹²^ORCID,Amoruso Fabrizio³,Argenziano Giuseppe⁴^ORCID,Bardazzi Federico⁵,Burlando Martina⁶^ORCID,Carrera Carlo Giovanni⁷,Damiani Giovanni⁸^ORCID,Dapavo Paolo⁹,Dini Valentina¹⁰^ORCID,Franchi Chiara⁸,Girolomoni Giampiero¹¹^ORCID,Guarneri Claudio¹²,Loconsole Francesco¹³,Sampogna Francesca¹⁴^ORCID,Travaglini Massimo¹⁵,Malagoli Piergiorgio¹⁶,Costanzo Antonio¹²^ORCID

Affiliation:

1. Dermatology Unit IRCCS Humanitas Research Hospital Rozzano (MI) Italy

2. Department of Biomedical Sciences Humanitas University Pieve Emanuele Italy

3. Dermatology Unit Azienda Ospedaliera di Cosenza Cosenza Italy

4. Department of Dermatology 'Luigi Vanvitelli' University School of Medicine Naples Italy

5. Dermatology Unit, Department of Specialistic, Diagnostic and Experimental Medicine S. Orsola‐Malpighi Hospital, University of Bologna Bologna Italy

6. Section of Dermatology, Department of Health Sciences (DISSAL) IRCCS San Martino University Hospital Genoa Italy

7. Fondazione Cà Granda IRCCS Maggiore Policlinico Hospital Milan Italy

8. Clinical Dermatology I.R.C.C.S. Istituto Ortopedico Galeazzi Milan Italy

9. Department of Biomedical Science and Human Oncology, Second Dermatologic Clinic University of Turin Turin Italy

10. Dermatology Unit, Department of Clinical and Experimental Medicine Ospedale Santa Chiara Pisa Italy

11. Department of Medicine, Section of Dermatology and Venereology University of Verona Verona Italy

12. Department of Biomedical and Dental Sciences and Morphofunctional Imaging University of Messina Messina Italy

13. Department of Dermatology University of Bari Bari Italy

14. Istituto Dermopatico Dell'Immacolata, (IDI) IRCCS Rome Italy

15. U.O.S.D. dermatologica ‐ centro per la cura della psoriasi, Ospedale Perrino Brindisi Italy

16. Department of Dermatology, Dermatology Unit Azienda Ospedaliera San Donato Milanese Milan Italy

Publisher

Wiley

Subject

Infectious Diseases,Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdv.18594

Reference32 articles.

1. Long-term safety and efficacy of adalimumab in psoriasis: a multicentric study focused on infections (connecting study)

2. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

3. Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 3-Year Experience with Tildrakizumab Treatment for Patients with Plaque Psoriasis in Clinical Practice;Dermatology and Therapy;2024-08-27

2. Safety of tildrakizumab: a disproportionality analysis based on the FDA adverse event reporting system (FAERS) database from 2018–2023;Frontiers in Pharmacology;2024-07-10

3. 52-Week Mid-term Efficacy of Tildrakizumab in Moderate-to-severe Psoriasis: A Real-life Multicenter Experience;Actas Dermo-Sifiliográficas;2024-07

4. [Artículo traducido] Eficacia a medio plazo (52 semanas) de tildrakizumab en el tratamiento de la psoriasis moderada a severa: un estudio multicéntrico de práctica clínica;Actas Dermo-Sifiliográficas;2024-07

5. Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study – IL PSO (Italian landscape psoriasis);Journal of Dermatological Treatment;2024-05-07